MyMD Pharmaceuticals, Inc., is a closely held company that is committed to developing and commercializing potentially potent small molecules that we believe offer significant therapeutic promise, particularly in devastating diseases such as cancers and various autoimmune disorders.
Through our commitment to patients suffering from devastating diseases, MyMD is developing a platform of potential products based on our proprietary small molecule.
MyMD’s early stage development program emphasizes collaboration with a team of highly experienced professionals and CROs. We believe that our collaborative strategy supports cost-effective product innovation and accelerated drug development.
The company has developed a small molecule for which we will seek clinical trial approval for the treatment of Androgenetic alopecia.
We are open to expressions of interest with respect to partnership at all stages of development.
Thank you for visiting MyMD Pharmaceuticals.
We are happy to answer any questions you may have about our company and for our exciting, breakthrough therapeutics. For more information, please fill out the form below we will be in touch with you shortly.
324 South Hyde Park Ave Suite 350, Tampa, FL 33606